» Articles » PMID: 36105401

Using Human Urinary Extracellular Vesicles to Study Physiological and Pathophysiological States and Regulation of the Sodium Chloride Cotransporter

Overview
Specialty Endocrinology
Date 2022 Sep 15
PMID 36105401
Authors
Affiliations
Soon will be listed here.
Abstract

The thiazide-sensitive sodium chloride cotransporter (NCC), expressed in the renal distal convoluted tubule, plays a major role in Na, Cl and K homeostasis and blood pressure as exemplified by the symptoms of patients with non-functional NCC and Gitelman syndrome. NCC activity is modulated by a variety of hormones, but is also influenced by the extracellular K concentration. The putative "renal-K switch" mechanism is a relatively cohesive model that links dietary K intake to NCC activity, and may offer new targets for blood pressure control. However, a remaining hurdle for full acceptance of this model is the lack of human data to confirm molecular findings from animal models. Extracellular vesicles (EVs) have attracted attention from the scientific community due to their potential roles in intercellular communication, disease pathogenesis, drug delivery and as possible reservoirs of biomarkers. Urinary EVs (uEVs) are an excellent sample source for the study of physiology and pathology of renal, urothelial and prostate tissues, but the diverse origins of uEVs and their dynamic molecular composition present both methodological and data interpretation challenges. This review provides a brief overview of the state-of-the-art, challenges and knowledge gaps in current uEV-based analyses, with a focus on the application of uEVs to study the "renal-K switch" and NCC regulation. We also provide recommendations regarding biospecimen handling, processing and reporting requirements to improve experimental reproducibility and interoperability towards the realisation of the potential of uEV-derived biomarkers in hypertension and clinical practice.

Citing Articles

Case Report: Familial hypocalciuric hypercalcemia type 1 with a novel mutation combined with Gitelman syndrome and a review of the literature.

He T, Li X, Li G, Wang W, Fu H, Gao Z Front Endocrinol (Lausanne). 2025; 16:1503128.

PMID: 40070587 PMC: 11893564. DOI: 10.3389/fendo.2025.1503128.


Extracellular vesicles: immunomodulation, diagnosis, and promising therapeutic roles for rheumatoid arthritis.

Abebaw D, Akelew Y, Adugna A, Teffera Z, Tegegne B, Fenta A Front Immunol. 2024; 15:1499929.

PMID: 39624102 PMC: 11609219. DOI: 10.3389/fimmu.2024.1499929.


Sodium Chloride Cotransporter in Hypertension.

Castagna A, Mango G, Martinelli N, Marzano L, Moruzzi S, Friso S Biomedicines. 2024; 12(11).

PMID: 39595146 PMC: 11591633. DOI: 10.3390/biomedicines12112580.


ENaCγ in Urinary Extracellular Vesicles as an Indicator of MR Signaling in Primary Aldosteronism.

Hayama Y, Kuribayashi-Okuma E, Fujii N, Ochiai-Homma F, Yamazaki O, Tsurutani Y Hypertension. 2024; 81(12):2457-2467.

PMID: 39319458 PMC: 11578056. DOI: 10.1161/HYPERTENSIONAHA.124.23379.


Diabetes with kidney injury may change the abundance and cargo of urinary extracellular vesicles.

Gu D, Ding Y, Jiang X, Shen B, Musante L, Holthofer H Front Endocrinol (Lausanne). 2023; 14:1085133.

PMID: 37077361 PMC: 10107408. DOI: 10.3389/fendo.2023.1085133.


References
1.
Puelles V, Hoy W, Hughson M, Diouf B, Douglas-Denton R, Bertram J . Glomerular number and size variability and risk for kidney disease. Curr Opin Nephrol Hypertens. 2010; 20(1):7-15. DOI: 10.1097/MNH.0b013e3283410a7d. View

2.
Williams C, Palviainen M, Reichardt N, Siljander P, Falcon-Perez J . Metabolomics Applied to the Study of Extracellular Vesicles. Metabolites. 2019; 9(11). PMC: 6918219. DOI: 10.3390/metabo9110276. View

3.
Erdbrugger U, Blijdorp C, Bijnsdorp I, Borras F, Burger D, Bussolati B . Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles. J Extracell Vesicles. 2021; 10(7):e12093. PMC: 8138533. DOI: 10.1002/jev2.12093. View

4.
Wang Z, Hill S, Luther J, Hachey D, Schey K . Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT). Proteomics. 2011; 12(2):329-38. PMC: 3517144. DOI: 10.1002/pmic.201100477. View

5.
Argaiz E, Chavez-Canales M, Ostrosky-Frid M, Rodriguez-Gama A, Vazquez N, Gonzalez-Rodriguez X . Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC. Am J Physiol Renal Physiol. 2018; 315(3):F734-F745. PMC: 6172580. DOI: 10.1152/ajprenal.00145.2018. View